Clinical Trial Update: Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

Early-stage clinical trial evaluating oxygen atomizing inhalation of EGCG for interstitial pneumonia in cancer patients (Phase 1/2). Status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Pneumonia
• Neoplasms Malignant

Drugs mentioned

• EGCG (epigallocatechin gallate)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Interstitial Pneumonia, Neoplasms Malignant | Phase 1, Phase 2 | Status: UNKNOWN